Sorafenib in elderly patients with advanced hepatocellular carcinoma: a case series. [electronic resource]
- Oncology 2013
- 265-72 p. digital
Publication Type: Journal Article
1423-0232
10.1159/000345558 doi
Aged Aged, 80 and over Antineoplastic Agents--therapeutic use Carcinoma, Hepatocellular--drug therapy Comorbidity Disease Progression Female Humans Liver Neoplasms--drug therapy Male Niacinamide--analogs & derivatives Phenylurea Compounds--therapeutic use Quality of Life Retrospective Studies Sorafenib Survival Rate Time Factors Treatment Outcome